PicksThatMove.com Announces Investment Opinion On: Human Genome Science Inc., General Electric Company, eBay Inc., NovaDel Pharma Inc., and Amylin Pharmaceuticals Inc.

PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the business development level to bring value to shareholders. Some of our past picks had soared over 200%. To view some of our profiled stocks, please visit our website at www.picksthatmove.com.

At PicksThatMove, our team scours the technical and financials of hundreds of companies to identify those stocks showing the greatest potential for growth.

The investment opinions offered below and in this press release are provided by Nick Hunter, RIA, of PicksThatMove.com

Human Genome Science Inc. (NASADQ: HGSI), $24.30, +$5.61, 30.02%, – saw its shares surge this today with over 38 million shares traded so far. The company announced that its drug Benlysta met the standards of BLISS-76, the second of two key Phase 3 trials in patients with systemic lupus erythematosus (SLE). Lupus is a disease where the body’s tissues are attacked by the immune system which results in chronic inflammation of the various tissues and organs of the body. It is being reported that the company plans on asking for regulator approval in 2010, and this could be the first treatment approved for patients with SLE in decades. Human Genome Science is a commercially focused biopharmaceutical company.

General Electric Company (NYSE: GE), $14.44, +$0.18, 1.26%, is making gains today with over 88 million shares traded. GE, a technology, media and financial services company provides products and services ranging from aircraft engines to medical imaging. The company announced today its technology development arm, GE Global Research, has been awarded a two-year, $1.2 million project to develop a low-cost transducer for portable ultrasound systems without compromising the image quality. This new development falls within GE’s healthymagination program with its aim to lower costs and provide more technological advances to underserved communities worldwide.

eBay Inc. (NASDAQ: EBAY), $22.41, $+0.14, 0.63%, is up $0.14 on no news and with over 19 million shares traded so far. Last month’s report released by the company confirmed its Q3 results with revenue of $2.2 billion, up $120.3 million from the same period of last year. The company contributes its rise in earnings to the continued growth among others to PayPal and Skype. eBay is an online marketplace for the purchase and sale of goods and services.

NovaDel Pharma Inc. (AMEX: NVD), $0.308, +$0.057, 22.47%, has made gains of over 22% today. The company announced last week that it has entered into a licensing agreement with Mist Acquisition, LLC, a privately held company to manufacture and commercialize the NitroMistR lingual spray version of nitroglycerine, a common treatment of angina pectoris. Under the terms, Mist will pay NovaDel a $1,000,000 licensing fee upon the execution of the agreement. Complete payment details are available on the company’s website. NovaDel is a pharmaceutical company responsible for developing oral spray formulations for a broad range of marketed drugs.

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN), $12.08, +$1.04, 9.42%, is making significant gains today after it was announced that the U.S. Food and Drug Administration has approved an expanded indication for BYETTA (exenatide) injection. BYETTA has now received approval for use as medication that can be used alone along with recommended diet and exercise to improve glycemic control in adults with type 2 diabetes. It was previously being used only for patients who were taking additional diabetes medications and had not achieved adequate glycemic control. Amylin is a company focused on using innovative science to offer new treatments for diabetes and obesity.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

Nick Hunter, RIA, of PicksThatMove.com is a member of the National Association of Securities Dealers, CRD number 2022366